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Abstract
The pancreas derives from cells in the ventral and dorsal foregut endoderm that express the transcription factor Pdx-1. These specified
cells give rise to the precursors of the endocrine, ductal, and exocrine pancreatic cells. The identification of transcription factors that regulate
the onset of Pdx-1 expression is therefore essential to understand pancreas development. No such factor that acts both in the ventral and
in the dorsal endoderm is known. We showed previously that the Onecut transcription factor HNF-6 promotes differentiation of the
endocrine cell precursors in which it stimulates expression of the proendocrine gene Ngn-3. By analyzing the phenotype of HNF-6 null mice,
we now demonstrate that HNF-6 also controls an earlier step in pancreas development. Indeed, the pancreas of Hnf6/ mice was
hypoplastic. This did not result from decreased proliferation or from increased apoptosis, but from retarded pancreatic specification of
endodermal cells. The onset of Pdx-1 expression was delayed both in the ventral and in the dorsal endoderm, leading to a reduction in the
number of endodermal cells expressing Pdx-1 at the time of pancreatic budding. In normal embryos, HNF-6 was detected in the endoderm
prior to the expression of Pdx-1. Moreover, HNF-6 could directly stimulate the Pdx1 promoter. Our data therefore identify HNF-6 as the
first factor known to control Pdx-1 expression both in the ventral and in the dorsal endoderm. We conclude that HNF-6 controls the timing
of pancreas specification and that HNF-6 acts upstream of Pdx-1 in this developmental process. Together with the known role of HNF-6
in pancreatic endocrine cell differentiation, our data point to HNF-6 as a key regulator of pancreas development.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
In the mouse embryo, the definitive endoderm becomes
regionalized by the end of gastrulation. This early pattern-
ing results from interactions with the mesoderm and ecto-
derm. When development proceeds, reciprocal interactions
between the endoderm and the mesoderm refine the antero-
posterior patterning of the primitive gut. The expression of
transcription factors along the anteroposterior axis of the
endoderm then specifies the presumptive territories of
endoderm-derived organs, such as the pancreas (reviewed
by Wells and Melton, 1999; Grapin-Botton and Melton,
2000; Cleaver and Krieg, 2001; Stainier, 2002). Knowing
how the expression of these transcription factors is con-
trolled is crucial to understand how organs develop from the
endoderm in normal and pathological conditions. In the
present paper, we focus on the regulation of pancreas spec-
ification.
The pancreas develops from a dorsal region and a ventral
region of the posterior foregut endoderm. The endoderm
gives rise to a dorsal bud and to a ventral bud, which fuse
to form a single organ. Studies of grafted mouse embryonic
tissues (Wessells and Cohen, 1967) showed that pancreas
specification occurs around the 8-somite stage, at embry-
onic day (E) 8. The dorsal foregut endoderm is then in
contact with the notochord, while the ventral foregut
endoderm fated to form the ventral pancreas and the liver is
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apposed to the cardiac mesoderm. On the dorsal side, sig-
nals originating from the notochord, possibly activin-B
and Fibroblast Growth Factor (FGF)-2 (Kim et al., 1997;
Hebrok et al., 1998), repress Sonic Hedgehog (Shh) expres-
sion in the pancreatic anlage. This repression is essential for
pancreas specification (Hebrok et al., 1998; Apelqvist et al.,
1997). On the ventral side, the emergence of the pancreas is
coordinated with that of the liver (Deutsch et al., 2001).
FGF from the cardiac mesoderm induces the local expres-
sion of Shh, which represses pancreatic gene expression in
the hepatic anlage and induces liver-specific expression.
Like for the dorsal pancreas, the ventral pancreas develops
only outside the endodermal region that expresses Shh.
The endodermal region committed to a pancreatic fate
expresses the transcription factor Pdx-1 (Offield et al., 1996;
Ahlgren et al., 1996). In Pdx1/ mouse embryos, the
formation of the pancreatic buds occurs, but the subsequent
morphogenesis of the pancreas is arrested (Jonsson et al.,
1994; Offield et al., 1996; Ahlgren et al., 1996). A role for
Pdx-1 in pancreas specification is supported by the obser-
vation that ectopic expression of Pdx-1 in chick embryo
endoderm causes cells to bud out of the gut epithelium and
Fig. 1. The pancreas of Hnf6/ embryos is hypoplastic. (A–H) Whole-mount immunohistochemistry experiments were performed on the embryonic days
indicated, with an anti-Pdx-1 antibody (brown staining) on digestive tracts dissected from control (A, C, E, and G) or Hnf6/ (B, D, F, and H) embryos.
(C–H) were cleared with benzylbenzoate/benzylalcohol, whereas (A) and (B) were not. (I, J) Immunohistochemistry experiments were performed with an
anti-Pdx-1 antibody on transverse sections of the ventral pancreatic bud on the day indicated. Pancreatic hypoplasia was striking in Hnf6/ embryos at all
the stages examined. At E10.75, the ventral pancreas of Hnf6/ embryos was not visible on whole-mount preparations (H) and was only detected as a small
bud on immunostained pancreas sections (J). d, duodenum; dp, dorsal pancreas; st, stomach; sp, spleen; vp, ventral pancreas.
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to initiate pancreatic differentiation (Grapin-Botton et al.,
2001). In keeping with these observations, lineage-tracing
experiments have shown that the three types of pancreatic
tissues (exocrine acini, endocrine islets, and ducts) are ex-
clusively derived from Pdx-1-expressing progenitors (Gu et
al., 2002).
Another transcription factor that is essential for early
pancreas development is Hb9. In the mouse, Hb9 expression
is found at the 8-somite stage in the entire dorsal gut
endoderm, and in the ventral endoderm at the prospective
pancreatic level. In Hb9/ mice, the dorsal region of the
gut epithelium fails to express Pdx-1 and to initiate a pan-
creatic specification program (Li et al., 1999; Harrison et al.,
1999). In contrast, the ventral pancreas develops and ex-
presses Pdx-1. This indicates that Hb9 regulates Pdx-1 ex-
pression in the dorsal endoderm, so that it is required for
specification of the dorsal pancreas, but that transcription
factors other than Hb9 stimulate the Pdx1 gene in the
ventral endoderm. The identification of transcription factors
that regulate the onset of Pdx-1 expression is therefore
essential to understand endoderm patterning and pancreas
development.
At later stages of pancreas development, several tran-
scription factors are involved in endocrine and exocrine cell
differentiation (Kim and Hebrok, 2001; Kawaguchi et al.,
2002; Edlund, 2002; Kim and MacDonald, 2002). The One-
cut transcription factor HNF-6 (Onecut 1-Mouse Genome
Informatics) (Lemaigre et al., 1996) is one of them. HNF-6
is the prototype of a class of homeoproteins conserved from
nematodes to humans (Lannoy et al., 1998). We (Landry et
Fig. 2. Pancreatic hypoplasia in Hnf6/ embryos is not due to defective
cell proliferation or to excess of apoptosis. (A, B) Immunofluorescence
analysis showed cells labeled for Pdx-1 (red), for BrdU (green), or for both
(yellow) in the dorsal pancreatic bud of E10.75 control (A) or Hnf6/ (B)
embryos. Cell proliferation was the same in control embryos and in
Hnf6/ embryos. (C, D) TUNEL assays were performed on E10.75
control (C) or Hnf6/ (D) embryos. Apoptotic cells are labeled in red. The
dotted line in (C) and (D) surrounds the dorsal pancreatic bud. Both in
control and in Hnf6/ embryos, no apoptotic cells were found in the
pancreatic epithelium, whereas but a few were observed in the pancreatic
mesenchyme. d, duodenum.
Fig. 3. The onset of Pdx-1 expression is delayed in Hnf6/ mice. (A–F)
Whole-mount immunohistochemistry experiments were performed with an
anti-Pdx-1 antibody on control (A, C, E) or Hnf6/ (B, D, F) embryos at
the stages of development indicated. The anterior part of the embryos is on
the left. At 16 somites, Hnf6/ embryos showed no Pdx-1-expressing cell
(B), in contrast to the high number of Pdx-1-positive cells present in the
ventral and dorsal endoderm of control embryos (A). In Hnf6/ embryos,
the first cells that weakly express Pdx-1 (surrounded by the dotted line)
were only found at the 19-somite stage in the dorsal endoderm (D), and at
the 22-somite stage in the ventral endoderm (F). The inset in (F) is a
blow-up of the square that delineates two Pdx-1-positive cells. db, dorsal
pancreatic bud; vb, ventral pancreatic bud.
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al., 1997) and others (Rausa et al., 1997) have shown that,
during early embryonic development, HNF-6 expression is
found in the pancreatic buds. At midgestation, HNF-6 is
expressed in the protodifferentiated epithelium, while in late
gestation, its expression is downregulated in pancreatic en-
docrine cells. We inactivated the mouse Hnf6 gene and
showed previously that HNF-6 controls pancreatic endo-
crine cell differentiation at the endocrine precursor stage
(Jacquemin et al., 2000). Consistent with this, HNF-6 was
shown to stimulate transcription of the proendocrine gene
Ngn3. Consequently, at birth, the pancreas of Hnf6/ mice
contained only a few endocrine cells and the islets of Lang-
erhans were absent. Later on, the number of endocrine cells
increased and islets were found in adult Hnf6/ mice.
However, the architecture of the islets was perturbed and
these mice were diabetic (Jacquemin et al., 2000). In an-
other work using transgenic mice (Gannon et al., 2000).
maintenance of HNF-6 expression in endocrine cells after
birth led to a similar phenotype, with disruption of islet
organization and diabetes. These results showed that HNF-6
plays a role in islet ontogeny and is critical for islet function.
In the present paper, we show that HNF-6 is also a critical
regulator of the timing of pancreas specification in both the
dorsal endoderm and the ventral endoderm, and that HNF-6
acts upstream of Pdx-1 in the specification cascade.
Materials and methods
Generation of Hnf6/ mice
To inactivate the Hnf6 gene, the proximal promoter re-
gion and the first exon were replaced by a neomycine
resistance gene (Jacquemin et al., 2000). The phenotype of
the Hnf6/ mice was normal. These animals were used as
controls together with wild-type littermates.
Immunohistochemistry, in situ hybridization, TUNEL
assay, and BrdU detection
Embryos were fixed at 4°C in 4% paraformaldehyde in
phosphate-buffered saline (PBS), incubated in 20% sucrose
in PBS at 4°C, embedded in PBS/15% sucrose/7.5% gelatin,
and frozen. Sections were cut at 10 m on a cryostat.
Primary antibodies were detected by immunoperoxidase
labeling using biotinylated sheep anti-rabbit immunoglobu-
lin G (Roche) and DAB (Dako). The following primary
antibodies were used: rabbit anti-HNF-6 (gift from R.
Costa), affinity-purified rabbit anti-Pdx-1 (gift from H. Ed-
lund, used for immunohistochemistry on whole-mount tis-
sue, see Fig. 1 and 3, and on sections, see Fig. 4), rabbit
anti-Pdx-1 (gift from C. Wright, used for experiments de-
scribed in Fig. 7, and from O. Madsen, used for experiments
on sections described in Fig. 1), rabbit anti-Hb9 (gift from
J. Kehrl), and rabbit anti-HNF-3 (gift from T. Jessell).
Whole-mount immunohistochemistry was performed as de-
scribed (Ohlsson et al., 1993). Briefly, embryos were fixed
in 4% paraformaldehyde in PBS at 4°C. Endogenous per-
oxidase activity was blocked by immersing the embryos in
methanol containing 3% hydrogen peroxide for 1 h. Affin-
ity-purified rabbit anti-Pdx-1 antibody was detected with the
Vectastain Elite ABC kit by using DAB (Vector). After
each antibody incubation, embryos were washed in TBST
(50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.1% Triton
X-100) for 5 h with five changes. Nonradioactive in situ
hybridization was performed as described (Fode et al.,
2000). The Shh and Oc2 antisense RNA probes synthesized,
respectively, from the Hh-16.1 plasmid (gift from A. Mc-
Mahon) and from the pBSmOC2/ISH plasmid (unpublished
observations) were labeled with digoxigenin–UTP and de-
tected with the TSA Biotin System (NEN). TUNEL assays
on 5-m paraffin sections were performed by using the in
situ cell death detection AP kit from Roche. Apoptotic cells
were labeled with Fast Red as substrate of the alkaline
phosphatase reaction. BrdU labeling was initiated by intra-
peritoneal injection (20 g/g body weight) of pregnant mice
90 min before sacrifice. Embryos were dissected and em-
bedded in paraffin. Double immunofluorescence analysis
for Pdx-1/BrdU was performed with rabbit anti-Pdx-1 and
mouse anti-BrdU (DSHB) antibodies. The secondary anti-
bodies used were FITC-conjugated anti-mouse (Jackson
Laboratory) and Texas Red-conjugated anti-rabbit (Vector)
antibodies.
Electrophoretic mobility shift assays (EMSA)
COS-7 cells were transfected with LipofectaminePlus
(Gibco-BRL) and 10 g of the pCMV-HNF-6 expression
vector. Twenty-four to 48 h after transfection, the cells were
harvested and cell extracts were obtained as described (Jac-
quemin et al., 2001). Extracts (5 l) from mock-transfected
cells or from cells transfected with the HNF-6 expression
vector were added to 15 l of 10 mM Hepes (pH 7.6), 1 mM
dithiothreitol, 1 mM MgCl2, 0.5 mM EDTA, 50 mM KCl,
10% (v/v) glycerol, 4 g of poly(dI-dC), and 32P-labeled
probe (30,000 cpm), and incubated on ice for 20 min. The
samples were loaded on a 6% polyacrylamide gel (acryl-
amide/bisacrylamide ratio of 38:2) in 0.25  Tris–borate–
EDTA buffer and electrophoresed at 200 V for 3 h. For the
supershift experiments, the pCMV-MCS vector (Stratagene)
containing the rat HNF-6 cDNA cloned downstream and in
frame of a Flag-coding sequence was transfected in HEK
293 cells, and cell extracts were obtained as described
above. Extracts were incubated with the anti-Flag M2 anti-
body (0.5 l) (Sigma) during 15 min prior to probe addition.
Plasmid construction and transfections
A plasmid containing a 9-kb XbaI–XbaI region of the
mouse Pdx1 gene (gift from C. Wright) was used to obtain
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a 4.5-kb SmaI–SmaI fragment corresponding to the Pdx1
promoter. This fragment was cloned in pBlueScript (Strat-
agene). A HindIII–SalI fragment of pGL3 basic (Promega),
containing the luciferase gene and the SV40 polyA signal,
was added downstream of the Pdx1 promoter to generate the
pPDX-luc reporter. Rat-1 fibroblasts were grown in Dulbec-
co’s modified Eagle medium (DMEM) supplemented with
10% fetal calf serum. Cells (4  104) on 24-well dishes
were cotransfected in serum-free DMEM by lipofection
using DOTAP (Roche) and 200 ng of pPDX-luc reporter,
150 ng of pECE-HNF6 expression vector, and 30 ng of
pRL138 (Lemaigre et al., 1996) coding for Renilla lucif-
erase as internal control. After 5 h, the medium was re-
placed by DMEM plus 10% fetal calf serum, and the cells
were incubated for 22 h before measuring luciferase activ-
ities using the Dual-Luciferase kit (Promega) and a TD-
20/20 luminometer (Promega). Luciferase activities were
expressed as the ratio of reporter activity (firefly luciferase)
to internal control activity (Renilla luciferase).
Results
The pancreas of Hnf6/ mice is hypoplastic
HNF-6 is expressed in the pancreas during embryogen-
esis (Landry et al., 1997; Rausa et al., 1997). To evaluate the
role of HNF-6 in pancreas development, we inactivated the
Hnf6 gene in the mouse by homologous recombination.
Analysis of newborn Hnf6/ mice revealed two distinct
pancreatic anomalies. The number of endocrine cells was
severely reduced (Jacquemin et al., 2000) and the pancreas
was hypoplastic (this paper). This pancreatic hypoplasia
persisted in adult Hnf6/ mice. We previously analyzed
the endocrine defect and showed that it results from im-
paired differentiation of the pancreatic endocrine cell pre-
cursors (Jacquemin et al., 2000). Since endocrine cells ac-
count for less than 10% of the total pancreatic mass (Slack,
1995), the pancreatic hypoplasia in Hnf6/ mice cannot
result exclusively from the endocrine defect. In the present
paper, we investigate the mechanism of this pancreatic hy-
poplasia.
We first determined the time at which hypoplasia occurs
in the Hnf6/ embryos. We had shown previously that
their pancreatic cells express normal levels of Pdx-1 from
embryonic day (E) 10.75 to E17.5 (Jacquemin et al., 2000).
To visualize the pancreas, we therefore performed whole-
mount immunohistochemistry with an anti-Pdx-1 antibody
on digestive tracts dissected from control or Hnf6/ em-
bryos. At E17.5, the pancreas was much smaller in Hnf6/
than in control embryos (Fig. 1A and B).Similar observa-
tions were made at E15.5 (Fig. 1C and D). At E12.5, before
fusion of the pancreatic buds, these buds were smaller and
less lobulated in Hnf6/ embryos than in control embryos
(Fig. 1E and F). At the 37-somite stage (approximately
E10.75), the dorsal and ventral buds could be identified by
Pdx-1 labeling of whole-mount tissue (Fig. 1G) in control
embryos. In contrast, the ventral pancreas was not visible in
Hnf6/ embryos (Fig. 1H). It was only on immunostained
pancreas sections that a small ventral bud could be detected
in these embryos (Fig. 1J), while the ventral bud of the
control embryos was well-developed (Fig. 1I). As to the
dorsal bud, it was present in Hnf6/ embryos (Fig. 1H),
but it was more elongated and flatter than in the control
embryos. To determine whether the dorsal pancreatic bud of
Hnf6/ embryos contains less epithelial cells than that of
control embryos, we sectioned three control and three
Hnf6/ embryos at the 33/34-somite stage (approximately
E10.5). Every other section was stained by immunohisto-
chemistry with an anti-Pdx-1-antibody (10–15 sections for
the Hnf6/ embryos, and 10–23 sections for the control
embryos), and the number of Pdx-1-expressing cells was
counted in the dorsal bud. We found that the number of cells
in Hnf6/ embryos was about half of that in control em-
bryos (Table 1). We concluded that the absence of HNF-6
leads to pancreatic hypoplasia and that this defect is ob-
served as early as E10.5.
Pdx-1 expression is delayed in Hnf6/ embryos
We next examined the three possible causes of pancre-
atic hypoplasia in Hnf6/ embryos, namely defective cell
proliferation, excess of apoptosis, or defective pancreatic
specification of endodermal cells. The proliferation of the
pancreatic epithelium was determined by BrdU incorpora-
tion on the remaining sections of the same three control and
three Hnf6/ embryos as those used for the cell count
experiment (Fig. 2A and B). Every other section was
costained by immunofluorescence with anti-Pdx-1 and anti-
BrdU antibodies. Results are presented in Table 1. The
proliferation index at E10.5 in Hnf6/ embryos was not
significantly different from that in control embryos. The
same was true at E12.5 (35.6% in Hnf6/ embryos and
35.2% in control embryos). TUNEL assays were performed
at E10.75 (Fig. 2C and D) and E12.5 (data not shown) on
pancreatic sections from four control embryos and four
Table 1
Cell count and proliferation index in the pancreas of E10.5 embryos
Control Hnf6/
Stage
(somites)
Number
of cells
Proliferation
index
Stage
(somites)
Number
of cells
Proliferation
index
33 1613 18.5 33 749 13.0
33 1223 26.9 33 725 28.3
33 1233 28.6 34 815 20.1
Note. Every other section was used for counting the Pdx-1-expressing
cells in the dorsal pancreatic bud. The other sections were used for deter-
mining the percentage of BrdU-positive cells in the Pdx-1-positive cell
population (proliferation index).
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Hnf6/ embryos (two control and two Hnf6/ embryos
per stage, two sections per embryo). No apoptotic cells were
found in the pancreas of control or Hnf6/ embryos. We
concluded that neither defective cell proliferation nor excess
of apoptosis accounts for the pancreatic hypoplasia in
Hnf6/ embryos.
We were left with the hypothesis that pancreas specifi-
cation is defective in Hnf6/ embryos. Pdx-1 is the earliest
marker of precursor cells of both the ventral and the dorsal
pancreas (Ohlsson et al., 1993; Ahlgren et al., 1996). We
therefore examined the time course of Pdx-1 expression in
control and Hnf6/ embryos, starting from the onset of
pancreatic specification of endodermal cells. Control em-
bryos at 16 somites (approximately E9) showed Pdx-1-
positive cells in the dorsal and ventral parts of the gut
endoderm (Fig. 3A). In contrast, no Pdx-1-expressing cells
were observed at that stage in Hnf6/ embryos (Fig. 3B).
It was only at the 19-somite stage that a few cells weakly
expressing Pdx-1 were found in Hnf6/ embryos, and
these cells were confined to the dorsal part of the gut
endoderm (Fig. 3D). In control embryos at that stage, the
number of Pdx-1-expressing cells had increased as com-
pared with the 16-somite stage (Fig. 3C). At the 22-somite
stage (approximately E9.5), control embryos showed nu-
merous Pdx-1-positive cells and typical dorsal and ventral
pancreatic buds (Fig. 3E). In Hnf6/ embryos, Pdx-1-
expressing cells were present in the dorsal region of the gut
endoderm, but their number was much lower than in control
embryos (Fig. 3F). Only two Pdx-1-expressing cells were
detected in the ventral part of the endoderm (inset in Fig.
3F). These experiments showed that the absence of HNF-6
delays the expression of Pdx-1 from the 11-somite stage to
the 19-somite stage in the dorsal endoderm and from the
8-somite stage to the 22-somite stage in the ventral
endoderm. This delay reduces the number of Pdx-1-express-
ing cells at the time when the pancreas buds out of the
endoderm.
HNF-6 and Pdx-1 are coexpressed in the endoderm
To approach the mechanism by which HNF-6 controls
Pdx-1 expression, we first determined whether these two
transcription factors are coexpressed in the endoderm. Ad-
jacent sections of the developing gut were analyzed by
immunohistochemistry (Fig. 4). Sections at the 8-somite
stage show the dorsal endoderm and the ventral endoderm.
The latter includes the prospective hepatic bud, in contact
with the cardiac mesoderm, and a lip which extends away
from the cardiac mesoderm and which will give rise to the
ventral pancreas. HNF-6 expression was detected in the
dorsal endoderm, as well as in the prospective hepatic bud
and in the endodermal lip (Fig. 4A). At that stage, no other
region of the endoderm showed a specific nuclear staining
for HNF-6. Pdx-1 expression was detected at the 8-somite
stage in a few cells of the endodermal lip (Fig. 4B). These
cells, which correspond to the first cells that express Pdx-1
in the embryo, will give rise to the ventral pancreatic bud.
No Pdx-1-expressing cells were found in the dorsal
endoderm (Fig. 4B). This is consistent with the notion that
Pdx-1 expression in the ventral endoderm precedes that in
the dorsal endoderm, where it appears between the 10- and
the 12-somite stages (Li et al., 1999). At the 13-somite
Fig. 4. The expression of HNF-6 in the gut endoderm precedes that of
Pdx-1. Immunohistochemistry experiments were performed with anti-
HNF-6 (A, C, E) or anti-Pdx-1 (B, D, F) antibodies on sagittal sections of
control embryos at the stages of development indicated. HNF-6 and Pdx-1
staining was performed on adjacent sections. The anterior part of the
embryos is up. At 8 somites, the endoderm expressed HNF-6, both in the
cells of its dorsal part and in the cells of the endodermal lip which will give
rise to the ventral bud (A). Some cells of this lip expressed also Pdx-1 (B).
At 13 somites, the ventral and dorsal endoderm showed Pdx-1-expressing
cells at locations wherefrom the ventral and dorsal pancreas will bud (D,
F). HNF-6 was also expressed by these cells (C, E). HNF-6 expression was
also detected in adjacent cells, so that its expression domain in the
endoderm was larger than that of Pdx-1. cm, cardiac mesoderm; de, dorsal
endoderm; el, endodermal lip; hb, prospective hepatic bud; ve, ventral
endoderm; vb, ventral pancreatic bud.
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stage, HNF-6 expression was observed in the ventral
endoderm at locations wherefrom the liver and the ventral
pancreas are budding (Fig. 4C), as well as in the dorsal
endoderm (Fig. 4E). At that stage, Pdx-1 was also expressed
in the ventral and dorsal endoderm (Fig. 4D and F), but its
domain of expression was smaller than that of HNF-6. We
concluded that Pdx-1-expressing cells in the prospective
pancreas also express HNF-6, and that expression of HNF-6
in the endoderm precedes that of Pdx-1.
The expression of Hb9, HNF-3, and Shh is normal in
Hnf6/ embryos
The data reported above showed that HNF-6 controls the
timing of Pdx-1 expression and that HNF-6 and Pdx-1 are
coexpressed in the endoderm. This suggested that HNF-6
could control directly the expression of Pdx-1 in the
endoderm but did not rule out that HNF-6 controls Pdx-1
expression via an indirect mechanism. To address the latter
possibility, we determined whether Hb9 (Li et al., 1999;
Harrison et al., 1999) and Shh (Hebrok et al., 1998;
Apelqvist et al., 1997), which are known regulators of Pdx-1
expression in the endoderm, are correctly expressed in
Hnf6/ embryos. We also tested the expression of HNF-
3, which controls expression of genes in the primitive gut
(reviewed by Zaret, 1999).
Shh has been reported to repress Pdx-1 expression and to
exert an inhibitory action on pancreas development (Hebrok
et al., 1998; Apelqvist et al., 1997). One possibility was that
the lack of Pdx-1 expression before the 19-somite stage in
Hnf6/ embryos results from inappropriate expression of
Shh in the region of the gut where Pdx-1 is normally
present. To test this hypothesis, we performed in situ hy-
bridization experiments with a Shh probe on sections of
control and Hnf6/ embryos at 12–13 somites (Fig. 5A
and B). Dorsal endoderm at the prospective pancreas level
was located by the presence of the notochord, which ex-
presses Shh, and by staining adjacent sections with anti-
Pdx-1 or anti-Hb9 antibodies. As expected, Shh was not
expressed in the dorsal endoderm of control embryos (Fig.
5A). Likewise, no Shh expression was observed in the
dorsal endoderm of Hnf6/ embryos (Fig. 5B). Similar
observations were made in the ventral endoderm of these
control or Hnf6/ embryos (data not shown).
Expression of the transcription factors Hb9 and HNF-3
was tested by immunohistochemistry. In control embryos at
13–15 somites, cells at the prospective pancreas level in the
ventral endoderm and in the dorsal endoderm expressed
Hb9 and HNF-3 (Fig. 5C and E), as expected. In Hnf6/
embryos, the expression of Hb9 and of HNF-3 was normal
in the ventral endoderm and in the dorsal endoderm (Fig. 5D
and F).
These observations indicated that Shh is correctly re-
pressed and that Hb9 and HNF-3 are correctly expressed
in Hnf6/ embryos. We therefore excluded that misexpres-
Fig. 5. The expression of Shh, Hb9, and HNF-3 is normal in Hnf6/
embryos. (A, B) In situ hybridization experiments were performed with
a digoxigenin-labeled Shh probe on sagittal sections of 13-somite
control (A) and 12-somite Hnf6/ (B) embryos. As expected, Shh
expression was present in the notochord and no Shh expression was
found in the dorsal endoderm of control or Hnf6/ embryos. (C–F)
Immunohistochemistry experiments were performed with anti-Hb9 at
the 13-somite stage (C, D) or anti-HNF-3 at the 15-somite stage (E, F)
antibodies on sagittal sections of control (C, E) or Hnf6/ (D, F)
embryos. The pattern of expression of Hb9 and of HNF3 in the
endoderm of Hnf6/ embryos was similar to that in the endoderm of
control embryos. The region labeled by Hb9 in the ventral endoderm
corresponds to the prospective ventral pancreatic bud. The anterior part
of the embryos is up. cm, cardiac mesoderm; de, dorsal endoderm; fp,
floor plate; hb, hepatic bud; no, notochord; ve, ventral endoderm.
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sion of Pdx-1 regulators contributes to the lack of initial
expression of Pdx-1 in the endoderm of Hnf6/ embryos.
HNF-6 controls the Pdx1 promoter
The data reported above suggested that HNF-6 controls
directly Pdx-1 expression. To test this, we determined
whether HNF-6 can bind to the Pdx1 gene promoter and
stimulate its transcriptional activity. Studies on transgenic
mice showed that the cis-acting elements of the mouse Pdx1
gene required for its embryonic and adult expression are
contained within 4.5 kb of 5 flanking sequence (Sharma et
al., 1996; Wu et al., 1997; Stoffers et al., 1999; Gerrish et
al., 2000; Gannon et al., 2001). We therefore searched for
potential HNF-6 sites in this region and tested the binding of
HNF-6 to the candidate cis-acting sequences by EMSA.
Three sequences, located from 4205 to 4212 bp (distal
site, PDX-D), from 2484 to 2491 bp (middle site, PDX-
M), and from 1769 to 1776 bp (proximal site, PDX-P)
upstream of the transcription initiation site, matched the
HNF-6 consensus (Lannoy et al., 1998). In EMSA, we
observed a protein/DNA complex when a probe correspond-
ing to the distal sequence was incubated with extracts of
COS-7 cells transfected with an HNF-6 expression vector.
This complex corresponded to the binding of HNF-6, as a
supershift was observed when an antibody was added in the
binding assay (Fig. 6A). Similar HNF-6/DNA complexes
were observed with probes corresponding to the middle site
or to the proximal site (Fig. 6A). When mutations were
introduced in the probes to destroy the HNF-6 binding
consensus, these HNF-6/DNA complexes were no longer
observed (.Fig. 6A), confirming that the binding of HNF-6
to these Pdx1 sequences is specific.
We then studied whether HNF-6 transactivates the Pdx1
gene promoter. The 4.5-kb Pdx1 promoter sequence was
cloned upstream of a luciferase reporter gene to generate
pPDX-luc. When pPDX-luc was cotransfected in Rat-1
cells with an HNF-6 expression vector, a 4.5-fold increase
in Pdx1 promoter activity was observed (Fig. 6B), showing
that HNF-6 can stimulate the Pdx1 promoter. We concluded
from this set of experiments that HNF-6 can bind to the
Pdx1 promoter and stimulate its activity.
The Onecut transcription factor OC-2 is expressed in the
pancreas of Hnf6/ embryos
We have shown above that the control exerted by HNF-6
on the Pdx1 gene is required only during the initial stages of
Pdx-1 expression. This suggested that another factor takes
over the role of HNF-6 in wild-type embryos or eventually
replaces HNF-6 in Hnf6/ embryos. A candidate was
OC-2 (Jacquemin et al., 1999), another member of the
Onecut class which displays DNA-binding and transcrip-
tional activation properties similar to those of HNF-6 (Jac-
quemin et al., 1999).
To test this hypothesis, we performed in situ hybridiza-
tion experiments with a mouse Oc2 probe on sections of
control or Hnf6/ embryos at the 23-somite stage (Fig. 7A
and B). Dorsal pancreatic buds were identified by Pdx-1
immunostaining on adjacent sections (Fig. 7C and D). As
expected, the number of Pdx-1-expressing cells in Hnf6/
embryos (Fig. 7D) was smaller than in control embryos
(Fig. 7C). Oc2 was expressed in the dorsal pancreatic bud of
control embryos (Fig. 7A) as well as of Hnf6/ embryos
(Fig. 7B). These data suggested that the eventual expression
of Pdx-1 in Hnf6/ embryos could be explained by a
compensatory role of OC-2.
Discussion
Our previous work on Hnf6/ mice has demonstrated
that HNF-6 is required in the pancreas for the differentiation
of the Ngn3-expressing endocrine cell precursors (Jacque-
min et al., 2000). On the other hand, overexpression studies
by Gannon et al. (2000) have suggested that downregulation
of HNF-6 in the differentiated endocrine cells during islet
ontogeny is required for the normal development of islets
and the function of  cells. Here, we show that, in addition
to its role in pancreatic endocrine cell differentiation,
HNF-6 has another function in pancreas development,
namely it controls the timing of pancreas specification.
HNF-6 and pancreas specification
Tissue graft experiments have shown that pancreas spec-
ification occurs around the 8-somite stage (Wessels and
Cohen, 1967). The expression of Pdx-1 in the endoderm
coincides with pancreas specification, as it is first detected
around this stage. Pdx-1-expressing cells are confined to the
prepancreatic regions of the endoderm, the onset of Pdx-1
expression being detected at the 8-somite stage for the
ventral endoderm and at the 10- to 12-somite stage for the
dorsal endoderm. Here, we show that, in Hnf6/ embryos,
the onset of Pdx-1 expression is delayed and that it starts
only at the 22-somite stage in the ventral endoderm and at
the 19-somite stage in the dorsal endoderm.
As a consequence of the delay in the onset of Pdx-1
expression, the number of Pdx-1-expressing cells available
for the formation of the pancreatic buds is reduced in
Hnf6/ embryos, and indeed the ventral bud, in which
Pdx-1 expression is more delayed, is more affected than the
dorsal bud. This leads to hypoplasia of the buds and ulti-
mately to hypoplasia of the entire pancreas at birth. Irre-
spective of this delay, one could argue that the amount of
endoderm present prior to pancreas specification is smaller
in Hnf6/ embryos than in control embryos, and that this
also contributes to pancreatic hypoplasia. This is unlikely,
as development of the stomach and the duodenum, two
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organs that also derive from the endoderm, is normal in
Hnf6/ mice (Fig. 1A and B).
HNF-6 is only required for the initial expression of
Pdx-1, suggesting that another factor compensates for the
absence of HNF-6 in the knockout embryos. The data pre-
sented here suggest that OC-2, a paralogue of HNF-6, could
play this role. As to the signaling mechanisms that trigger
pancreas specification in Hnf6/ embryos, one has to con-
sider that in normal embryos Pdx-1 expression is induced at
the 8- to 12-somite stage by signaling from the notochord,
which is then adjacent to the gut endoderm (Kim et al.,
1997). In Hnf6/ embryos, the onset of Pdx-1 expression
cannot be ascribed to notochord signaling, since at the
19-somite stage, the notochord and the gut endoderm are
separated from each other by the midline fusion of the
dorsal aortas. However, mesenchyme-derived signals could
play a role. Indeed, mesenchyme development is not af-
fected in Hnf6/ embryos, as suggested by the normal
mesenchymal expression of Isl-1 (Jacquemin et al., 2000).
Pdx-1 is the only transcription factor known to function-
ally delineate the boundaries of the prospective pancreas in
the endoderm at the time of pancreas specification. How-
ever, pancreas specification also requires the transcription
factor Hb9. The lack of Hb9 expression is associated with
the absence of Pdx-1 in the dorsal endoderm and with the
failure to develop a dorsal pancreatic bud (Li et al., 1999;
Harrison et al., 1999), while on the ventral side, Pdx-1
expression and pancreatic budding still occur. The domain
of Hb9 expression in the dorsal endoderm is broader than
that of HNF-6, which in turn is broader than that of Pdx-1.
Therefore, the simple combination of the expression pat-
terns of HNF-6 and Hb9 does not explain the more re-
stricted expression pattern of Pdx-1. Other factors, or the
modulation of the activity of HNF-6 and Hb9 by extrinsic
signals, could account for the spatially restricted expression
of Pdx-1.
To our knowledge, no regulator of Pdx-1 in the ventral
endoderm has been identified. The Hnf6/ embryos
showed defective expression of Pdx-1 not only in the dorsal
endoderm, but also in the ventral endoderm. Our data there-
fore identify HNF-6 as the first factor known to control both
ventral and dorsal pancreas specification.
HNF-6 controls Pdx-1 expression in the endoderm
During pancreas development, the Pdx1 gene is ex-
pressed in the prepancreatic endoderm and in the pluripotent
pancreatic epithelium. At later stages, Pdx-1 is predomi-
nantly found in  cells. Using transgenic mice, it was shown
that a 4.5-kb sequence upstream of the transcription initia-
tion site of the mouse Pdx1 gene is sufficient to drive
expression of a LacZ reporter gene according to the devel-
opmental and adult-specific pattern of Pdx-1 (Wu et al.,
1997; Stoffers et al., 1999; Gannon et al., 2001). Compar-
ison of the human, chicken, and mouse genes revealed an
area of significant sequence identities from 2800 to
1700. Further sequence analysis allowed to divide this
area in three subdomains called, from 5 to 3, I, II, and III
(Gerrish et al., 2000). A gene fragment encompassing sub-
domains I and II confers expression of a transgene in the
pancreatic endocrine cells, while a fragment spanning sub-
domain III confers expression at E11.5 throughout the pan-
creatic epithelium (Gannon et al., 2001). The middle
(2484/2491) and proximal (1769/1776) HNF-6
binding sites described here are located within subdomains
I and III, respectively. Moreover, these two sites are con-
served from mice to humans in these important cis-regula-
tory elements of the Pdx1 gene, which points to their phys-
iological significance. The distal HNF-6 site (4205/
4212) is not conserved.
Several tissue-specific transcription factors are known to
control the Pdx1 gene promoter during differentiation of the
 cells (Wu et al., 1997; Marshak et al., 2000; Gerrish et al.,
2000, 2001; Ben-Shushan et al., 2001; Shih and Stoffel,
2001; Samaras et al., 2002). Among them, only HNF-3 has
been shown to control the expression of genes in the
endoderm (reviewed by Zaret, 1999). As to Hb9, no direct
interaction of this transcription factor with regulatory se-
quences of the Pdx1 gene has been described. In fact, it is
likely that Hb9 controls the Pdx1 gene indirectly, as Hb9
reportedly functions as a transcriptional repressor via its
interaction with the corepressor Groucho (Muhr et al.,
2001). Here, we show that HNF-6 binds to and transacti-
vates the Pdx1 promoter. These data, and our finding that
the onset of Pdx-1 expression in the embryo depends on
HNF-6, suggest that HNF-6 is a direct stimulator of Pdx1 in
the endoderm. HNF-6 could trigger chromatin opening over
the Pdx1 gene through its known interaction with the his-
tone acetyltransferases CBP and pCAF (Lannoy et al.,
2000), thereby allowing access of other transcription factors
to DNA.
Roles of HNF-6 in pancreas development and
differentiation
Previous data have shown that HNF-6 regulates pancre-
atic endocrine cell differentiation and that HNF-6 is also
important for the formation of the islets of Langerhans
(Jacquemin et al., 2000; Gannon et al., 2000). The present
data demonstrate an additional, earlier role for HNF-6 in
pancreas development, namely in the timing of pancreas
specification. Distinctly timed roles have also been defined
for Pdx-1 and for Hb9, as both are required not only for the
specification of the pancreas, but also for endocrine cell
differentiation or function (reviewed in Edlund, 2002). Like
for Pdx-1 and Hb9, HNF-6 exerts its distinct roles by con-
trolling different target genes. It controls the specification
process via Pdx-1 expression and endocrine differentiation
via Ngn3 expression. In the absence of HNF-6, pancreas
specification is delayed, but pancreatic cells express normal
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levels of Pdx-1 at E10.75 (Jacquemin et al., 2000). It is
therefore unlikely that the endocrine defect observed at
E12.5 in Hnf6/ embryos results from the delay in pan-
creas specification. Still, the diabetes observed in adult
Hnf6/ mice could result from both defective endocrine
differentiation with severe reduction of Glut2 expression
(Jacquemin et al., 2000) and pancreas hypoplasia with sub-
sequent reduction in the number of islets of Langerhans.
Actually, in these mice, the diabetic syndrome probably also
results from the observed decrease in expression of the
glucokinase gene in liver (Lannoy et al., 2002).
In conclusion, our present and previous (Jacquemin et
al., 2000) results identify HNF-6 as a key regulator of
Fig. 6. HNF-6 controls the Pdx1 gene promoter. (A) HNF-6 binds to three
sites in the Pdxl gene promoter. The sequence of the proximal (PDX-P),
middle (PDX-M), and distal (PDX-D) HNF-6 binding sites in the Pdxl
promoter is given. Arrows delineate the HNF-6 binding consensus, and
Fig. 7. Oc2 expression is detected in the pancreas of control embryos and
Hnf6/ embryos. In situ hybridization (A, B) and immunohistochemistry
(C, D) experiments were performed respectively with a digoxigenin-la-
beled Oc2 probe and with anti-Pdx-1 antibodies on sections of 23-somite
control (A, C) and Hnf6/ (B, D) embryos. (A, C) and (B, D) are adjacent
sections. Pdx-1 labeling was used to localize the dorsal pancreatic bud. The
number of Pdx-1 expressing cells was smaller in Hnf6/ embryos than in
control embryos, as expected (see Fig. 3). Oc2 expression was found in the
dorsal pancreatic bud and adjacent endoderm of the control (A) and
Hnf6/ (B) embryos. db, dorsal pancreatic bud.
lower case letters indicate the nucleotides mutated in the corresponding
probes. EMSA were performed with extracts from mock-transfected
COS-7 cells () or from COS-7 cells transfected with the HNF-6 expres-
sion vector (), as indicated above each lane. The radioactive probes used
(wt, wild type; mut, mutated) are indicated below the lanes. An HNF-6–
DNA complex was observed with each of the wild-type probes, but not
with the mutated probes, in the presence of extracts of cells transfected
with the HNF-6 expression vector. A supershift was observed in the
presence of an antibody against Flag-tagged HNF-6. (B) HNF-6 stimulates
the Pdxl promoter. Rat-1 cells were transiently cotransfected with the
firefly luciferase reporter containing 4.5 kb of the Pdxl promoter sequence
(pPDX-luc) and an internal control plasmid coding for Renilla luciferase,
in the presence of the HNF-6 expression vector () or of an empty vector
() (mean  s.e.m., n  3). The activity of the Pdxl promoter was
stimulated 4.5-fold in the presence of the HNF-6 expression vector.
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pancreas specification and endocrine cell differentiation.
Perturbations in pancreas function are associated with dia-
betes. A therapeutic approach aims at engineering cells to
produce insulin and transplanting them into patients. It has
been suggested that simple gene combinations may be suf-
ficient to generate a pancreatic endocrine cell type from
embryonic endodermal cells (Grapin-Botton et al., 2001).
The Hnf6 gene is an obvious candidate in such combina-
tions.
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